Moreover, Bai et al.47established a mouse model of unilateral ureteral obstruction (UUO) and discovered that ruxolitinib treatment attenuated UUO‐induced inflammation, oxidative stress, and apoptosis by inhibiting the activation of the Akt/mTOR/Yap pathway. The gene discussed is MTOR; the disease is Ureteral obstruction.